Tri-linyah Kit
Product Images NDC 16714-363

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tri-linyah (NDC 16714-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

1 (Image 01)
Tri-Linyah is a type of oral contraceptive pill that comes in a pack of 28 tablets. 21 tablets are active and color-coded green (Day 1-7), light blue (Day 8-14), and blue (Day 15-21). 7 tablets are white and inactive. The administration of the active tablets begins on the first day of menstrual bleeding or the first Sunday after the onset of menstruation. The inactive tablets are taken for 7 consecutive days after the active ones, then the following pack should be started on the same day of the week as the first cycle. The patient should use non-hormonal contraception for the first seven days of the first cycle pack to avoid pregnancy. The complete instructions for administration are available in the FDA-Approved Patient Labeling.*
FDA Label Image

2 (Image 02)

2 (Image 02)
This text provides instructions on what to do when one or two Tri-Linyah tablets are missed in different weeks of the cycle. It also advises the use of additional contraception if the patient has sex within seven days after missing the tablets. If three or more tablets are missed, the patient must begin a new pack immediately, with non-hormonal contraception as backup.*
FDA Label Image

3 (Image 03)

FDA Label Image

4 (Image 04)

4 (Image 04)
The text provides a summary of pharmacokinetic parameters of norelgestromin, norgestrel, and ethinyl estradiol during a three-cycle study, including information on Cmax, tmax, and AUCc-24n. It also includes the mean and standard deviation values for each parameter. The text provides specific values for each analyte and cycle day as well.*
FDA Label Image

5 (Image 05)

5 (Image 05)
The table displays results from two multicenter, placebo-controlled trials for acne vulgaris indications. The population analyzed was the intent-to-treat population. The table shows the observed means at baseline and after six months of using Norgestimate and Ethinyl Estradiol tri-cycle tablets compared to placebo. The number of inflammatory and non-inflammatory lesions were counted and presented, and the percentage of the difference in the counts between the groups was shown. The results suggest a reduction in lesion counts after six months with the use of Norgestimate and Ethinyl Estradiol tri-cycle tablets. LOCF stands for Last Observation Carried Forward.*
FDA Label Image

6 (Image 06)

FDA Label Image

7 (Image 07)

7 (Image 07)
This text appears to be describing various methods of birth control and their effectiveness. It includes different forms of contraception such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patches, vaginal rings with hormones, condoms, and diaphragms. The text also mentions the effectiveness in preventing pregnancies ranging from fewer than 10 to 20, 85 or more per 100 women in one year. Additionally, strategies for avoiding pregnancy such as abstinence during the most fertile days of the month and using spermicide are included, but not using any form of contraception altogether is not recommended.*
FDA Label Image

8 (Image 08)

8 (Image 08)
This appears to be a template for a weekly pill organizer with each day of the week labeled and instructions to take pills from left to right. The design features a green color scheme with a light blue border.*
FDA Label Image

9 (Image 09)

FDA Label Image

10 (Image 10)

FDA Label Image

11 (Image 11)

11 (Image 11)
TRI-LINYAH is a prescription medication containing Norgestimate and Ethinyl Estradiol. It is used as a contraceptive to prevent pregnancy. The medication comes in tablet form and should be taken as directed by a healthcare provider.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.